Abstract
Background: Blood group, bleeding time (BT), and clotting time (CT) are essential clinical parameters, particularly in preoperative assessments and transfusion medicine. Aims and Objectives: This study aimed to investigate the association between ABO blood groups and BT/CT, as well as potential gender-based differences in these metrics. Materials and Methods: A cross-sectional study was conducted among 132 first-year medical students in Nepal. Blood groups were determined via agglutination, BT via the Dukes method, and CT via the capillary tube method. Results: Both BT and CT were higher in males than females, with significant differences found in mean BT ($P=0.05$). While mean BT did not vary significantly across blood groups, CT showed a significant association ($P=0.05$), with Group B individuals exhibiting longer tendencies. Conclusion: The study suggests a correlation between Blood Group B and prolonged clotting times, warranting larger multicentric studies to explore underlying factors like von Willebrand factor levels.
Introduction
Before surgical procedures or blood transfusions, clinicians routinely evaluate Bleeding Time (BT) and Clotting Time (CT). BT measures the "vascular-platelet phase"—the efficiency of platelets in forming an initial plug—while CT measures the "coagulation phase," or the formation of stable fibrin threads.
While these tests are foundational, results often vary across populations. Some research suggests that individuals with Blood Group O may experience longer bleeding due to lower levels of von Willebrand factor (vWF). This study seeks to clarify these associations within a specific demographic of young medical students in Nepal.
Methods
The researchers conducted a cross-sectional study of 132 first-year medical students (68 males, 64 females) at KIST Medical College, Nepal. Three standard hematological techniques were employed:
- Agglutination Method: To determine ABO and Rh blood groups.
- Dukes Method (BT): A standardized skin puncture on a fingertip, with blood dabbed every 30 seconds until cessation.
- Capillary Tube Method (CT): Blood drawn into a capillary tube and broken at 30-second intervals until a visible fibrin thread appeared.
Statistical analysis was performed using SPSS-20, utilizing ANOVA for blood group comparisons and Student’s t-tests for gender differences.
Results and Data Distribution
The study cohort was nearly balanced by gender (51.5% male, 48.5% female). The distribution of blood groups followed a specific regional pattern, with Group O being the most prevalent.
Key Findings
- The "Group B" Deviation: Contrary to some literature favoring Group O, this study found that Blood Group B exhibited the longest mean BT (182.05s) and CT (326.14s). Group A had the shortest times.
- Gender Dimorphism: Males showed significantly longer bleeding times than females ($P=0.05$). Males had a mean BT of 174.95s compared to 154s for females.
- Clotting Time Significance: While BT did not show a statistically significant difference across all blood groups combined, the CT did ($P=0.05$).
Discussion
The finding that males have longer bleeding times is notable, as some literature suggests estrogen might increase bleeding time by decreasing fibrinogen levels. The authors observed that their results align with certain regional studies but contradict others, highlighting the complexity of hormonal and genetic influences on primary hemostasis.
The significant association of CT with blood groups—specifically the longer times in Group B—suggests that ABO antigens may influence the coagulation cascade differently than previously thought in this specific population. However, the study did not find a significant correlation related to Rh factor, likely due to the small sample size of Rh-negative individuals (n=4).
Conclusion
This study identifies a tendency for longer bleeding and clotting times in individuals with Blood Group B and in male participants. These findings underscore the potential for blood group and gender to serve as subtle predictors of hemostatic behavior. The authors recommend future multicentric studies with larger, more diverse populations and direct measurement of plasma von Willebrand factor (vWF) to definitively map these genetic relationships.
Summary updated